The trajectory of copyright's flagship drug presents a nuanced case for stakeholders in the drug sector. While initially a tremendous success, producing huge profits, the exclusivity end and the subsequent entry of https://knockoff199269.angelinsblog.com/40526256/the-little-copyright-and-the-pharmaceutical-industry-a-hazardous-bet